» Articles » PMID: 6704938

Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical Significance of Chromosomal Abnormalities in Acute Nonlymphoblastic Leukemia

Overview
Date 1984 Mar 1
PMID 6704938
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Seven hundred sixteen newly diagnosed patients were studied, to determine the clinical significance of chromosome analysis in ANLL. Karyotypes were classified in two ways. Cases were grouped into three categories, based on the presence of normal and abnormal metaphases. Cases were grouped into 12 categories based on more specific chromosome abnormalities (modified Chicago Classification). Both methods of classifying karyotypes, but especially the Chicago Classification, resulted in groups of patients with de novo ANLL with significantly different presenting clinical and hematologic features, including FAB type, leukocyte count, percent peripheral myeloblasts, platelet count, and DIC. Among patients with de novo ANLL, karyotypes, when classified according to the Chicago Classification, significantly correlated with frequency of initial complete remission and survival; the presence of normal and abnormal metaphases correlated with duration of first remission and survival. Among 305 intensively treated patients, the Chicago Classification also correlated with duration of first remission. Although both ways of classifying karyotype correlated with survival, even when other major risk factors in ANLL were considered, only the Chicago Classification was an independent prognostic factor among the intensively treated patients.

Citing Articles

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.

Bui N, Przybyl J, Trabucco S, Frampton G, Hastie T, van de Rijn M Clin Sarcoma Res. 2019; 9:12.

PMID: 31528332 PMC: 6739971. DOI: 10.1186/s13569-019-0122-5.


Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials.

Strickland S, Sun Z, Ketterling R, Cherry A, Cripe L, Dewald G Leuk Res. 2017; 59:55-64.

PMID: 28551161 PMC: 5573653. DOI: 10.1016/j.leukres.2017.05.010.


Cytogenetic and morphological analysis of de novo acute myeloid leukemia in adults: a single center study in jordan.

Ayesh M, Khassawneh B, Matalkah I, Alawneh K, Jaradat S Balkan J Med Genet. 2013; 15(1):5-10.

PMID: 24052716 PMC: 3776649. DOI: 10.2478/v10034-012-0001-3.


Genetic alterations in children and adolescents with acute myeloid leukaemia.

Verdeguer A Clin Transl Oncol. 2010; 12(9):590-6.

PMID: 20851799 DOI: 10.1007/s12094-010-0563-z.


Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.

Armand P, Kim H, DeAngelo D, Ho V, Cutler C, Stone R Biol Blood Marrow Transplant. 2007; 13(6):655-64.

PMID: 17531775 PMC: 2743535. DOI: 10.1016/j.bbmt.2007.01.079.